Literature DB >> 9701372

Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984.

G D Cascino1, D Hesdorffer, G Logroscino, W A Hauser.   

Abstract

PURPOSE: To analyze the nonfatal adverse events (AE) associated with a first episode of status epilepticus (SE).
METHODS: We performed a population-based retrospective cohort study to determine the morbidity of SE. Participants included 184 residents of Rochester, Minnesota who experienced nonfebrile SE between 1965 and 1984.
RESULTS: The etiology of SE was acute symptomatic in 100 patients and unprovoked in 84 patients. The most common seizure-types were continuous partial (n=56, 30%), generalized convulsive (n=52, 28%), and generalized with focal features (n=32, 17%). Morbidity related to SE was noted in 5 of the 146 patients (3.4%) surviving 30 days. The AE included hemiparesis (n=3), encephalopathy (n=2), mental retardation (n=1), and aphasia (n=1). All patients with morbidity had an acute symptomatic (n=4) or remote symptomatic (n=1) etiology. Thirty-four patients (18.5%) had a second episode of SE.
CONCLUSIONS: Based on this retrospective study, significant morbidity related to SE is uncommon and is associated with the underlying etiology.

Entities:  

Mesh:

Year:  1998        PMID: 9701372     DOI: 10.1111/j.1528-1157.1998.tb01176.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists.

Authors:  M Holtkamp; F Masuhr; L Harms; K M Einhäupl; H Meierkord; K Buchheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

Review 2.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

3.  The epidemiology of status epilepticus in the United States.

Authors:  Bhavpreet S Dham; Krystal Hunter; Fred Rincon
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

4.  Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.

Authors:  M Holtkamp; J Othman; K Buchheim; H Meierkord
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 5.  Generalised convulsive status epilepticus: an overview.

Authors:  R Nandhagopal
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

6.  Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis.

Authors:  Felicia Qashu; Taiza H Figueiredo; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Amino Acids       Date:  2009-01-07       Impact factor: 3.520

7.  Status epilepticus in the elderly: differential diagnosis and treatment.

Authors:  Elizabeth Ann Mauricio; William David Freeman
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-29       Impact factor: 2.570

8.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

9.  Temporal lobe epilepsy after refractory status epilepticus: an illustrative case and review of the literature.

Authors:  J Gordon Boyd; Derek B Debicki; G Bryan Young
Journal:  Epilepsy Res Treat       Date:  2012-04-10

Review 10.  Would people living with epilepsy benefit from palliative care?

Authors:  Benzi M Kluger; Cornelia Drees; Thomas R Wodushek; Lauren Frey; Laura Strom; Mesha-Gay Brown; Jacquelyn L Bainbridge; Sarah N Fischer; Archana Shrestha; Mark Spitz
Journal:  Epilepsy Behav       Date:  2020-11-24       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.